EXQUALT Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for EXQUALT with the United States Patent and Trademark Office. The USPTO has given the EXQUALT trademark a serial number of 86450965. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 2, 2024. This trademark is owned by Glaxo Group Limited. The EXQUALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
exqualt

General Information

Serial Number86450965
Word MarkEXQUALT
Filing DateTuesday, November 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 2, 2024
Registration Number5383127
Registration DateTuesday, January 23, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, March 17, 2015ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 14, 2014NEW APPLICATION ENTERED
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Thursday, March 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 13, 2015ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 19, 2015SOU TEAS EXTENSION RECEIVED
Thursday, November 19, 2015SOU EXTENSION 1 FILED
Thursday, November 19, 2015SOU EXTENSION 1 GRANTED
Saturday, November 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 16, 2017SOU EXTENSION 4 FILED
Tuesday, May 31, 2016SOU EXTENSION 2 FILED
Friday, July 1, 2016SOU EXTENSION 2 GRANTED
Saturday, July 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2016SOU EXTENSION 3 FILED
Wednesday, December 14, 2016SOU EXTENSION 3 GRANTED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 16, 2017SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2017SOU EXTENSION 4 GRANTED
Thursday, December 14, 2017NOTICE OF ALLOWANCE CANCELLED
Saturday, December 16, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 2, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

exqualt pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological